Management algorithm for patients with chronic-phase myelofibrosis. ESA, erythropoiesis stimulating agent; GIPSS, Genetically Inspired Prognostic Scoring System; MIPSS, Mutation-Enhanced International Prognostic Scoring System; MYSEC-PM, myelofibrosis secondary to PV and ET-prognostic model.